Sight Sciences, Inc.
SGHT · XNASCIK 1531177fmd_1KVWV7XNRW0QRDYPY0SD4P8NFNManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 28 | 49 | 71 | 81 | 80 | 77 |
| Cost of revenue | 9 | 9 | 12 | 12 | 12 | 11 |
| Gross profit | 18 | 40 | 59 | 69 | 68 | 67 |
| Research and development | 9 | 16 | 23 | 18 | 18 | 15 |
| Selling, general and administrative | 42 | 76 | 120 | 109 | 101 | 89 |
| Total operating expenses | 51 | 92 | 143 | 126 | 119 | 104 |
| Operating income | (32) | (51) | (84) | (57) | (51) | (37) |
| Interest expense | 2 | 4 | 4 | 5 | 5 | 5 |
| Interest and investment income | 0 | – | – | – | – | – |
| Other non-operating income (expense) | (0) | (7) | 2 | (0) | (0) | (0) |
| Income before taxes | (35) | (63) | (86) | (55) | (51) | (38) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (35) | (63) | (86) | (56) | (52) | (38) |
| Net income | (35) | (63) | (86) | (56) | (52) | (38) |